Estudiante de Medicina, RCM 🇵🇷 Política Pública, UChicago
Puerto Rico
Joined April 2017
- Tweets2K
- Following526
- Followers6.6K
- Likes12.9K
Carlo Bosques retweeted
Ahead of Print | Analyzing real-world brinkmanship, Jason Buxbaum of @Brown_SPH and coauthors note that “the availability of public price transparency data may be contributing to a possible increase in aggressive negotiations.” healthaffairs.org/doi/10.137…
Excelente librito. Lo recomiendo. Bien entretenido, se lee más como un cuento que como historia. Muchos paralelos entre los esfuerzos para contener la plaga en la Italia de los 1600’s (incluso tenían rastreo de contactos!) y la pandemia del 2020.
Carlo Bosques retweeted
Modelo de servicios médicos en PR (no es bueno para nadie, excepto para las aseguradoras):
-Medicaid (pobres y algunos trabajadores): mucha cubierta, pero pocos proveedores. No pueden pagar proveedores que no aceptan plan
-sin plan
Abro hilo
Carlo Bosques retweeted
WP: Mathematical Foundations of Health Economics: Arrow, Garber, and the Economics
of Medical Uncertainty, by Jakub Ryłow
buff.ly/Wz3Le4L
Carlo Bosques retweeted
The synthetic biologist Kate Adamala coaxed a cellular soup of nonliving biomolecules enclosed in a membrane to act somewhat like a living thing. The synthetic cell even grew and divided into daughter cells. quantamagazine.org/for-the-f…
Carlo Bosques retweeted
Over the past year, nearly all net job growth has come from healthcare and social assistance, per WSJ
Carlo Bosques retweeted
Arguing that any attempt to address a problem will have counterproductive effects? Absolutely a type of guy on here.
From Albert O. Hirschman's The Rhetoric of Reaction (1991)
Carlo Bosques retweeted
BREAKING: At least 164 people are dead and 971 injured after powerful earthquakes rock Venezuela, the country's acting president says. apnews.com/article/venezuela…
MA en Política Pública ✅
Con una concentración en políticas públicas de salud 🩺
Lo más que extrañaré de la Universidad de Chicago es su excelente biblioteca; pasé demasiadas horas ahí, y aprendí muchísimo.
Ahora, a terminar el MD 🔜
Carlo Bosques retweeted
Debemos resistir a la mercantilización de las necesidades humanas esenciales. El agua, los alimentos y la asistencia sanitaria no pueden estar subordinados a consideraciones de mercado o a intereses geopolíticos. El acceso a una alimentación adecuada es un derecho humano fundamental arraigado en la dignidad de cada persona. Responder a esta necesidad no solo sirve para aliviar el sufrimiento, sino también para afrontar las causas que subyacen a la inestabilidad geopolítica. De hecho, la seguridad alimentaria es un componente esencial de la seguridad global e integral. vatican.va/content/leo-xiv/e…
Lo que ando leyendo para relajarme: La Anatomía de la Melancolía. Un libro interesantísimo del siglo 17, en donde el autor inglés Robert Burton analiza la melancolía (es decir, depresión, entre otras condiciones). Él tenía depresión, y escribió el libro para curarse.
Carlo Bosques retweeted
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Carlo Bosques retweeted
People who don't follow cancer research often ask me why we haven't cured cancer. That perception masks a wonderful reality: We make amazing, stepwise progress every year, and the result is that many people live much longer today than they would have previously.
Right now we're in the thick of the annual meeting of the American Society of Clinical Oncology, the biggest research meeting on new cancer medicines, and this morning a bunch of really important studies dropped. I'm going to review them here.
This first image is the result for daraxonrasib, a treatment for pancreatic cancer that is generating consdirable excitement. The green line is the probability of living for patients who got the new drug; the gray one is the chemo control group.
If you follow cancer drugs, a chart like this will make your breath hitch a little. I'm going to review these and some other data here.
Carlo Bosques retweeted
MedPAC has done a real service continually updating rigorous estimates of overpayments to MA plans.
Recent risk adjustment changes made a real dent, but Medicare is still paying MA plans ~14% more than it would cost to cover comparable beneficiaries in Traditional Medicare.
Carlo Bosques retweeted
El recurso legal que radicó Professional Hospital Guaynabo cuestiona la implementación de un modelo de pago que se basa en el cuadro clínico del paciente | Detalles aquí: bit.ly/42xuLSI
Carlo Bosques retweeted
Powerful editorial on corporitization of medicine.
1. Trainees are not cheap labor
2. Margin focus threatens trust.
3. Leaders need to stay in touch with clinical care
nejm.org/doi/full/10.1056/NE…
Carlo Bosques retweeted
Most ‘synergistic’ cancer drug combinations fail in the clinic.
Why?
A new paper revisits 100 years of drug combination research to understand the matters key to clinical success
doi.org/10.1016/j.medj.2026.…
1/8
Carlo Bosques retweeted
In the medicine of the future, molecular physicians built from a patient’s own cells might ferret out cancer, repair injured tissue, and even remove plaque from blood vessels.
Researchers have now taken a step toward that vision: They’ve coaxed tracheal cells to form coordinated groups called organoids that can propel themselves with tiny appendages. When added to wounded neurons in the lab, these “anthrobots” helped neurons repair themselves.
Learn more on #DayOfImmunology: scim.ag/4sZFIXT
Carlo Bosques retweeted
Comparto columna sobre el PC 1115 que interesa eliminar la Ley 47-2021 y el mecanismo que crea para la revisión periódica del salario mínimo
En PR hay aprox. 250,000 personas que trabajan por salario mínimo. Representa el 33% del empleo en sector privado
elnuevodia.com/opinion/punto…
